0001140361-13-044991.txt : 20131205
0001140361-13-044991.hdr.sgml : 20131205
20131205100538
ACCESSION NUMBER: 0001140361-13-044991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131203
FILED AS OF DATE: 20131205
DATE AS OF CHANGE: 20131205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYBERONICS INC
CENTRAL INDEX KEY: 0000864683
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 760236465
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 100 CYBERONICS BLVD
CITY: HOUSTON
STATE: TX
ZIP: 77058
BUSINESS PHONE: (281) 228-7200
MAIL ADDRESS:
STREET 1: 100 CYBERONICS BLVD
CITY: HOUSTON
STATE: TX
ZIP: 77058
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verratti Mark
CENTRAL INDEX KEY: 0001517026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19806
FILM NUMBER: 131258968
MAIL ADDRESS:
STREET 1: 100 CYBERONICS BLVD
CITY: HOUSTON
STATE: TX
ZIP: 77058
4
1
doc1.xml
FORM 4
X0306
4
2013-12-03
0
0000864683
CYBERONICS INC
CYBX
0001517026
Verratti Mark
100 CYBERONICS BLVD
HOUSTON
TX
77058
0
1
0
0
VP Global Sales
Common Stock
2013-12-03
4
M
0
18750
37.90
A
71469
D
Common Stock
2013-12-03
4
S
0
18750
71.1188
D
52719
D
Option to purchase common stock
37.90
2013-12-03
4
M
0
18750
0.00
A
2015-03-07
Common Stock
18750
49423
D
Represents weighted average selling price. Securities were sold through approximately 72 separate sales on the transaction date at prices ranging from $70.87 to $71.70. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected.
Reporting Person was granted an option to purchase 50,000 shares of common stock on March 7, 2005. The option is fully vested and expires March 7, 2015. The option was subject to certain vesting and forfeiture requirements in accordance with the terms of the applicable Stock Option Agreement.
Mark S. Verratti
2013-12-05